The Journal of Urology
Volume 184, Issue 4 , Pages 1267-1272 , October 2010

Relief of Stent Related Symptoms: Review of Engineering and Pharmacological Solutions

Received 6 February 2010

References 

  1. Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol. 1967;97:840
  2. Nabi G, Cook J, N'Dow J, et al. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. BMJ. 2007;334:572
  3. Nabi G, Downey P, Keeley F, et al. Extra-corporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2007;CD006029
  4. Tolley D. Ureteric stents, far from ideal. Lancet. 2000;356:872
  5. Joshi HB, Stainthorpe A, MacDonagh RP, et al. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 2003;169:1065
  6. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral Stent Symptom Questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003;169:1060
  7. Abrams P, Cardozo L, Khoury S, et al. Incontinence: Basics & Evaluation. Plymouth, United Kingdom: Health Publications Ltd; 2005;vol 1, p 10
  8. Liatsikos EN, Karnabatidis D, Kagadis GC, et al. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study. Eur Urol. 2007;51:217
  9. Beiko DT, Knudsen BE, Denstedt JD. Advances in ureteral stent design. J Endourol. 2003;17:195
  10. Lennon GM, Thornhill JA, Sweeney PA, et al. ‘Firm’ versus ‘soft’ double pigtail ureteric stents: a randomised blind comparative trial. Eur Urol. 1995;28:1
  11. Joshi HB, Chitale SV, Nagarajan M, et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol. 2005;174:2303
  12. Davenport K, Kumar V, Collins J, et al. Prospective randomised trial comparing the Bard Inlay™ ureteric stent with the Boston Scientific Polaris™ ureteric stent using the validated Ureteric Stent Symptom Questionnaire. BJU Int. 2008;101(suppl.):52
  13. Lee C, Kuskowski M, Premoli J, et al. Randomized evaluation of ureteral stents using validated symptom questionnaire. J Endourol. 2005;19:990
  14. Erturk E, Sessions A, Joseph JV. Impact of ureteral stent diameter on symptoms and tolerability. J Endourol. 2003;17:59
  15. Ho CH, Chen SC, Chung SD, et al. Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol. 2008;22:1427
  16. Al-Kandari AM, Al-Shaiji TF, Shaaban H, et al. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol. 2007;21:698
  17. Dunn MD, Portis AJ, Kahn SA, et al. Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. J Endourol. 2000;14:195
  18. Lingeman JE, Preminger GM, Goldfischer ER, et al. Assessing the impact of ureteral stent design on patient comfort. J Urol. 2009;181:2581
  19. Olweny EO, Portis AJ, Sundaram CP, et al. Evaluation of a chronic indwelling prototype mesh ureteral stent in a porcine model. Urology. 2000;56:857
  20. Lingeman JE, Preminger GM, Berger Y, et al. Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. J Urol. 2003;169:1682
  21. Chew BH, Lange D, Paterson RF, et al. Next generation biodegradable ureteral stent in a Yucatan pig model. J Urol. 2010;183:765
  22. Krambeck AE, Walsh RS, Denstedt JD, et al. A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol. 2010;183:1037
  23. Davenport K, Timoney AG, Keeley FX. A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int. 2006;98:651
  24. Davenport K, Timoney AG, Keeley FX. Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res. 2007;35:207
  25. Deliveliotis C, Chrisofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?. Urology. 2006;67:35
  26. Beddingfield R, Pedro RN, Hinck B, et al. Alfuzosin to releave ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol. 2009;181:170
  27. Damiano R, Autorino R, De Sio M, et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol. 2008;22:651
  28. Wang CJ, Huang SW, Chang CH. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res. 2009;37:147
  29. Norris RD, Sur RL, Springhart WP, et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutinin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology. 2008;71:792
  30. Giannarini G, Keeley FX, Valent F, et al. Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int. 2010;Epub ahead of print

 Nothing to disclose.

 Editor's Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1580 and 1581.

PII: S0022-5347(10)03818-8

doi: 10.1016/j.juro.2010.06.043

The Journal of Urology
Volume 184, Issue 4 , Pages 1267-1272 , October 2010

Article Tools